Skip to search formSkip to main contentSkip to account menu

MT 141

Known as: MT-141 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
MT-141, a new cephamycin (7 alpha-methoxy-cephalosporin) antibiotic with a D-cysteine moiety in its 7 beta-side chain, has… 
1985
1985
MT-141 inhibited 90% of the clinical isolates of Bacteroides fragilis at 3.13 mg/l, whereas six reference cephem antibiotics… 
1985
1985
The bactericidal and morphological effects under drug-decreasing conditions of cefminox (MT-141), cefoxitin, cefmetazole… 
1984
1984
A teratogenicity study of MT-141 was performed in SD rats and Japanese white rabbits. The pregnant rats were administered… 
1984
1984
In this subacute study, male and female rats were administered with 100, 200, 400, 800 and 1,600 mg/kg/day of MT-141 through an… 
1984
1984
The antibacterial activity of MT-141 against Escherichia coli and Proteus morganii in compromised mice was investigated and… 
1984
1984
A fertility study of MT-141 was performed in SD rats with the intramuscular (i.m.) injections at the dose levels of 400, 800 and… 
1984
1984
The results on pharmacological effects of MT-141 were as follows. MT-141 did not exert effect on central nervous system in mice… 
1983
1983
C-7 and C-3 substituents of a new antibiotic SF-1623 were chemically modified to improve the bioactivity, and substituent effect…